全文获取类型
收费全文 | 11988篇 |
免费 | 506篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 162篇 |
儿科学 | 144篇 |
妇产科学 | 140篇 |
基础医学 | 1627篇 |
口腔科学 | 424篇 |
临床医学 | 741篇 |
内科学 | 2899篇 |
皮肤病学 | 208篇 |
神经病学 | 996篇 |
特种医学 | 629篇 |
外科学 | 1772篇 |
综合类 | 65篇 |
一般理论 | 1篇 |
预防医学 | 412篇 |
眼科学 | 273篇 |
药学 | 813篇 |
中国医学 | 23篇 |
肿瘤学 | 1205篇 |
出版年
2023年 | 62篇 |
2022年 | 123篇 |
2021年 | 209篇 |
2020年 | 109篇 |
2019年 | 132篇 |
2018年 | 159篇 |
2017年 | 131篇 |
2016年 | 172篇 |
2015年 | 196篇 |
2014年 | 250篇 |
2013年 | 287篇 |
2012年 | 503篇 |
2011年 | 545篇 |
2010年 | 292篇 |
2009年 | 293篇 |
2008年 | 478篇 |
2007年 | 552篇 |
2006年 | 538篇 |
2005年 | 501篇 |
2004年 | 521篇 |
2003年 | 573篇 |
2002年 | 533篇 |
2001年 | 427篇 |
2000年 | 484篇 |
1999年 | 434篇 |
1998年 | 158篇 |
1997年 | 140篇 |
1996年 | 127篇 |
1995年 | 112篇 |
1994年 | 105篇 |
1993年 | 113篇 |
1992年 | 345篇 |
1991年 | 317篇 |
1990年 | 276篇 |
1989年 | 257篇 |
1988年 | 244篇 |
1987年 | 220篇 |
1986年 | 187篇 |
1985年 | 171篇 |
1984年 | 138篇 |
1983年 | 117篇 |
1979年 | 75篇 |
1978年 | 65篇 |
1977年 | 63篇 |
1975年 | 72篇 |
1974年 | 56篇 |
1973年 | 56篇 |
1972年 | 66篇 |
1968年 | 68篇 |
1967年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Muta T Nakanishi H Yasunaga M Senba S Murakami H Kan S Ueda Y Fujisaki T 《Gan to kagaku ryoho. Cancer & chemotherapy》2011,38(2):237-241
Recently, the safety and effectiveness of bortezomib for patients with multiple myeloma and renal failure has been reported. In this study, we retrospectively analyzed the 8 myeloma patients with renal failure who have received bortezomib in our hospital.One patient had already required constant hemodialysis before bortezomib.Bortezomib treatment was performed for 229 days, during which time it was injected 30 times.The other 2 patients with chronic renal failure also showed no further renal impairment due to bortezomib.In the remaining 5 patients, serum creatinine levels decreased through 2 cycles(total: 8 injection)of bortezomib treatment.Two patients were complicated with herpes zoster, and 2 patients were complicated with neuropathy in grade 3.We showed the safety and efficacy of bortezomib in Japanese patients with multiple myeloma complicated with renal failure.We should positively consider the therapeutic choice of bortezomib for the refractory myeloma with renal failure. 相似文献
992.
Ebisui C Okada K Nishigaki T Owada Y Nagase H Mukai R Momozane T Murakami M Ide Y Yanagisawa T Murata K Yokouchi H Tamai M Kinuta M 《Gan to kagaku ryoho. Cancer & chemotherapy》2011,38(12):2143-2145
The patient was an 80-year-old female with chief complaint of anemia. She was diagnosed as a type 3 gastric cancer (por/tub2) of the esophagogastric junction by gastrointestinal endoscopy in November 2010. CT scan revealed no distant metastasis and we diagnosed as c-stage II B (T4aN0M0). However, severe COPD was detected by the respiratory function test. Considering her age and respiratory function, we decided that total gastrectomy under general anesthesia was difficult. She was treated with radiation( 50.4 Gy/28 Fr) and the combination chemotherapy of S-1( 80 mg/m2, day 1-21) plus low-dose CDDP (6 mg/m2, day 1-5, 8-12, 15-19) during her hospitalization, and treated with S-1 mono-therapy as an outpatient. The tumor was reduced and the hemorrhage was not seen though the response was SD. Moreover, she did not experience any adverse event of grade 3 or more. The chemoradiation therapy appears to be effective for patients of adenocarcinoma of the esophagogastric junction. 相似文献
993.
994.
995.
Manabe Hideyuki Murakami Yoshihiro El-Aasr Mona Ikeda Tsuyoshi Fujiwara Yukio Ono Masateru Nohara Toshihiro 《Journal of natural medicines》2011,65(1):176-179
A tomato saponin, esculeoside A, may be metabolized into various steroidal hormones such as pregnane derivatives that are
expected to exhibit various bioactivities in the body, such as anti-osteoporosis, anti-menopausal disorder and anti-tumor
actions. Therefore, we attempted to examine the esculeoside A contents of fresh tomatoes, tomatoes boiled in water, tomatoes
heated using a microwave oven, freeze-dried tomatoes, and commercially available processed tomato products contained in plastic
bottles and cans, in order to develop a health food. 相似文献
996.
997.
Yoshikawa Y Sato A Tsujimura T Morinaga T Fukuoka K Yamada S Murakami A Kondo N Matsumoto S Okumura Y Tanaka F Hasegawa S Hashimoto-Tamaoki T Nakano T 《International journal of oncology》2011,39(6):1365-1374
Array-based comparative genomic hybridization analysis was performed on 21 malignant mesothelioma (MM) samples (16 primary cell cultures and 5 cell lines) and two reactive mesothelial hyperplasia (RM) primary cell cultures. The RM samples did not have any genomic losses or gains. In MM samples, deletions in 1p, 3p21, 4q, 9p21, 16p13 and 22q were detected frequently. We focused on 3p21 because this deletion was specific to the epithelioid type. Especially, a deletion in 3p21.1 region carrying seven genes including SEMA3G was found in 52% of MM samples (11 of 14 epithelioid samples). The allele loss of 3p21.1 might be a good marker for the epithelioid MM. A homozygous deletion in this region was detected in two MM primary cell cultures. A heterozygous deletion detected in nine samples contained the 3p21.1 region and 3p21.31 one carrying the candidate tumor suppressor genes such as semaphorin 3F (SEMA3F), SEMA3B and Ras association (RalGDS/AF-6) domain family member?1 (RASSF1A). SEMA3B, 3F and 3G are class 3 semaphorins and inhibit growth by competing with vascular endothelial growth factor (VEGF) through binding to neuropilin. All MM samples downregulated the expression of more than one gene for SEMA3B, 3F and 3G when compared with Met5a, a normal pleura-derived cell line. Moreover, in 12 of 14 epithelioid MM samples the expression level of SEMA3A was lower than that in Met5a and the two RM samples. An augmented expression of VEGFA was detected in half of the MM samples. The expression ratio of VEGFA/SEMA3A was significantly higher in the epithelioid MMs than in Met5a, RMs and the non-epithelioid MMs. Our data suggest that the downregulated expression of SEMA3A and several SEMA3s results in a loss of inhibitory activities in tumor angiogenesis and tumor growth of VEGFA; therefore, it may play an important role on the pathogenesis of the epithelioid type of MM. 相似文献
998.
999.
Fabio S. Murakami Karen L. Lang Cassiana Mendes Ariane P. Cruz Marco A.S. Carvalho Filho Marcos A.S. Silva 《Journal of pharmaceutical and biomedical analysis》2009
The physical characterization of active pharmaceutical substances is crucial to the successful development of the final drug product. The different solid forms and variations in the degree of crystallinity can lead to significantly different physical and chemical properties, including color, morphology, stability, dissolution and bioavailability. In the case of omeprazole sodium (OMS), its chemical structures contain a specific number of water molecules (hydrate). The behavior of pharmaceutical hydrates has become the object of increasing attention over the past decade, primarily due to the potential impact of hydrates on the development process and dosage form performance. The present study was designed to characterize and evaluate the crystallinity of omeprazole sodium, dehydrated omeprazole sodium (DOMS) and omeprazole free base (OM) using a variety of techniques including thermal analysis (thermogravimetry/derivative thermogravimetry (TG/DTG) and differential scanning calorimetry (DSC)), diffuse reflectance infrared Fourier transform (DRIFT) spectroscopy, scanning electron microscopy (SEM) and X-ray powder diffraction (XRPD). Furthermore, an NMR spectroscopy study was also carried out to clarify the conformation and crystal structure. 相似文献
1000.
Performance characteristics of the Architect brain natriuretic peptide (BNP) assay: a two site study
Mongia SK La'ulu SL Apple FS Ler R Murakami MM Roberts WL 《Clinica chimica acta; international journal of clinical chemistry》2008,391(1-2):102-105
INTRODUCTION: Brain natriuretic peptide (BNP) is produced by the ventricles of the heart and is a biomarker for heart failure. Several commercial assays are now available. We evaluated the performance characteristics of the ARCHITECT BNP assay. METHODS: We evaluated the limit of blank, limit of detection, linearity and imprecision. Method comparison studies were performed with 3 other automated BNP assays including the ADVIA Centaur, AxSYM, and UniCel DxI 800 methods. RESULTS: The mean LOB and LOD of the Architect assay were 3.5 and 5.8 ng/L, respectively. Imprecision studies yielded within run CVs of 1.1 to 5.1% and total CVs of 2.3 to 5.3% using human plasma based multi-constituent controls at concentrations of 92, 500, and 3500 ng/L. The maximum deviation from the target recovery for dilution linearity was 9.6%. Concordance with other BNP assays at a 100 ng/l cutoff was 91 to 98% and kappa statistics were 0.78 to 0.96. The mean difference between the Architect and Advia Centaur methods was positive. For the other methods, the mean difference with the Architect was negative. CONCLUSIONS: The Architect BNP assay shows good performance characteristics with total imprecision < or =5.3%. It agrees well with the Advia Centaur, AxSYM, and UniCel DxI BNP assays. 相似文献